VitusCare, a leading dialysis care provider in North India, has announced plans to raise over USD 10 million in its upcoming funding round. This move will support the company’s mission to improve the accessibility and affordability of quality dialysis care across India and other underserved global markets. VitusCare is currently engaging with venture capital funds, healthcare-focused private equity firms, and impact investors for this funding round.
The funding will enable VitusCare to drive its next phase of rapid growth. The company plans to triple its network of dialysis centres within the next 12 months, having already doubled its network in just seven months since its Series A funding. The focus will remain on expanding into underserved areas with limited access to quality dialysis services.
Operational and technological support systems will also receive attention, enhancing scalability and operational management across the network of centres. Additionally, VitusCare will invest in upskilling dialysis technicians, paramedics, and other clinical staff as part of its strategy to maintain a competitive workforce and ensure efficient service delivery.
Earlier this year, VitusCare secured USD 2.7 million in Series A funding led by Tomorrow Capital. This funding supported the company’s operations, allowing it to expand its presence in Tier 2 and Tier 3 cities across North India. VitusCare continues to focus on maintaining sustainable profitability and advancing its impact-driven mission in underserved regions.
Prabhat Shrivastava, Founder & CEO of VitusCare, stated, “We take immense pride in having built a highly scalable, operationally efficient, and EBITDA-positive business. Our Series A round in early 2024 allowed us to refine our playbook for rapid scale-up, doubling our footprint to 50+ centres in just seven months. We stayed true to our ethos of expanding deeper into Bharat and becoming the first dialysis provider in many locations.”
Shrivastava further added, “Our next challenge is to shift into hyper-growth mode, targeting an enhanced footprint and doubling our monthly dialysis sessions. The upcoming funding round will fuel this ambition and support our plans for international expansion into underserved markets globally. Already, a challenger brand in India’s dialysis care sector, this will put us on track to become the third-largest player nationwide by March 2026.”
Founded in 2017, VitusCare was established to transform renal care in underserved North Indian cities. The founding team includes Dr Saurabh Pokhariyal, Prabhat Shrivastava, and Pankaj Tandon, whose combined expertise has addressed gaps in high-quality dialysis care delivery. The company has adopted a capital-efficient business model, using proprietary strategies integrating technology and skilled personnel to identify underserved locations and rapidly set up dialysis centres.
VitusCare’s goal is to expand into international markets with unmet dialysis care needs. Prabhat Shrivastava highlighted, “Our expansion into underserved markets has positioned us as a key player addressing the white spaces in Bharat’s dialysis ecosystem. In the next 5 years, we plan to operate 500+ centres across India, becoming one of the largest renal care providers in Bharat while replicating this impact in international markets. We chose to tackle a challenging segment of the market by providing quality dialysis in underserved regions, and we have mastered this approach. Our goal is to build deeper networks in these areas, maintaining a strong margin profile while delivering impactful care at scale. A key objective is to improve longevity of a patient’s life, showcasing how a VitusCare patient can outlive India’s current dialysis patient average lifespan of 2-3 years. Another critical outcome is ensuring every dialysis patient enjoys a normal, active life as long as they consistently visit a VitusCare centre.”
VitusCare is targeting investors aligned with its vision of improving healthcare accessibility in underserved areas and recognising the opportunities in India’s growing dialysis care sector. The company is on track to triple its network by March 2025 and aims to grow its monthly recurring revenue from Rs 2.5 crore to Rs 5 crore while achieving Rs 100 crore annual recurring revenue (ARR) by March 2026.